ALFONSO
GOMEZ DE ITURRIAGA PIÑA
PROFESORADO AGREGADO
University Hospital of Geneva
Ginebra, SuizaPublications in collaboration with researchers from University Hospital of Geneva (10)
2024
-
PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial
European urology oncology, Vol. 7, Núm. 3, pp. 462-468
2023
-
Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer
World Journal of Urology, Vol. 41, Núm. 12, pp. 3829-3838
2022
-
Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial
Radiotherapy and Oncology, Vol. 172, pp. 1-9
-
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus
Radiotherapy and Oncology, Vol. 176, pp. 199-207
2021
-
Extreme hypofractionation with sbrt in localized prostate cancer
Current Oncology, Vol. 28, Núm. 4, pp. 2933-2949
-
Salvage local treatment for localized radio-recurrent prostate cancer: A narrative review and future perspectives
Future Oncology, Vol. 17, Núm. 31, pp. 4207-4219
-
The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases
European Urology Focus
2020
2019
-
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy
European Urology, Vol. 76, Núm. 6, pp. 732-739
-
Oligometastatic prostate cancer: The game is afoot
Cancer Treatment Reviews, Vol. 73, pp. 84-90